(Total Views: 299)
Posted On: 05/08/2019 5:34:00 PM
Post# of 154912
My question is this: is this milestone a stock price booster or another step towards approval?
During the last section when NP mentions an upcoming major milestone, he also mentions the FDA as well. Could the milestone be the next part of the BLA submission? If so, that’s won’t be a booster. Could it be the pivotal trial design? Maybe, but again, that’s not a stock price booster because we’ll be waiting another 18 months or so for full results (unless the trail is smaller and shorter in duration).
During the last section when NP mentions an upcoming major milestone, he also mentions the FDA as well. Could the milestone be the next part of the BLA submission? If so, that’s won’t be a booster. Could it be the pivotal trial design? Maybe, but again, that’s not a stock price booster because we’ll be waiting another 18 months or so for full results (unless the trail is smaller and shorter in duration).
(0)
(0)
